Original language | English |
---|---|
Pages (from-to) | 474-476 |
Number of pages | 3 |
Journal | Obstetrical and Gynecological Survey |
Volume | 74 |
Issue number | 8 |
DOIs |
|
State | Published - Aug 1 2019 |
Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study
Joan L. Walker, Mark F. Brady, Lari Wenzel, Gini F. Fleming, Helen Q. Huang, Paul A. Disilvestro, Keiichi Fujiwara, David S. Alberts, Wenxin Zheng, Krishnansu S. Tewari, David E. Cohn, Matthew A. Powell, Linda Van Le, Susan A. Davidson, Heidi J. Gray, Peter G. Rose, Carol Aghajanian, Tashanna Myers, Angeles Alvarez Secord, Stephen C. Rubin
- University of Oklahoma
- Roswell Park Cancer Institute
- University of California at Irvine
- University of Chicago
- Women and Infants Hospital of Rhode Island
- Saitama Medical University
- University of Arizona
- Ohio State University
- Washington University St. Louis
- University of North Carolina at Chapel Hill
- University of Colorado Anschutz Medical Campus
- University of Washington
- Cleveland Clinic Foundation
- Memorial Sloan-Kettering Cancer Center
- University of Connecticut
- Duke University
- University of Pennsylvania
Research output: Contribution to journal › Comment/debate